Tonix Pharmaceuticals Holding (TNXP) Prepaid Assets (2010 - 2026)
Tonix Pharmaceuticals Holding's (TNXP) quarterly Prepaid Assets came in at $9.2 million in Q1 2026, up 762.9% year-on-year from $1.1 million in Q1 2025, and up 459.58% quarter-over-quarter from $1.6 million in Q4 2025.
Tonix Pharmaceuticals Holding (TNXP) Prepaid Assets (2010 - 2026) Analysis & Trends
Tonix Pharmaceuticals Holding's Prepaid Assets history runs 17 years deep, the most recent figure standing at $9.2 million for Q1 2026.
- On a quarterly basis, Prepaid Assets rose 762.9% year-over-year to $9.2 million in Q1 2026; TTM through Mar 2026 was $9.2 million, a 762.9% increase from a year earlier, with the FY2025 full-year figure at $1.6 million, up 18.53% from the prior year.
- Prepaid Assets grew to $9.2 million in Q1 2026 per TNXP's latest filing, from $1.6 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $14.8 million in Q2 2022 and bottomed at $686000.0 in Q2 2025.
- The 5-year median for Prepaid Assets is $9.2 million (2023), against an average of $7.4 million.
- Across the five-year window, Prepaid Assets plunged 91.77% in 2025 and soared 762.9% in 2026, its largest moves.
- Year by year, Prepaid Assets stood at $1.3 million in 2022, then soared by 620.08% to $9.2 million in 2023, then plunged by 84.84% to $1.4 million in 2024, then advanced by 18.53% to $1.6 million in 2025, then surged by 459.58% to $9.2 million in 2026.
- Per Business Quant, the three latest TNXP Prepaid Assets figures stand at $9.2 million (Q1 2026), $1.6 million (Q4 2025), and $8.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 473.74 Bn | 468.95 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.07 Bn | 114.82 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.00 Bn | 61.24 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn |
| 10 | Tonix Pharmaceuticals Holding | 142.14 Mn | 142.14 Mn | 5.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.23 Mn |
| Dec 31, 2025 | 1.65 Mn |
| Sep 30, 2025 | 8.81 Mn |
| Jun 30, 2025 | 686,000.00 |
| Mar 31, 2025 | 1.07 Mn |
| Dec 31, 2024 | 1.39 Mn |
| Sep 30, 2024 | 2.13 Mn |
| Jun 30, 2024 | 8.34 Mn |
| Mar 31, 2024 | 10.70 Mn |
| Dec 31, 2023 | 9.18 Mn |
| Sep 30, 2023 | 9.54 Mn |
| Jun 30, 2023 | 12.01 Mn |
| Mar 31, 2023 | 11.75 Mn |
| Dec 31, 2022 | 1.28 Mn |
| Sep 30, 2022 | 11.16 Mn |
| Jun 30, 2022 | 14.77 Mn |
| Mar 31, 2022 | 12.55 Mn |
| Dec 31, 2021 | 1.48 Mn |
| Sep 30, 2021 | 12.11 Mn |
| Jun 30, 2021 | 11.55 Mn |